Imunon Inc (IMNN)
1.42
0.00 (0.00%)
USD |
NASDAQ |
May 23, 10:03
Imunon Accounts Payable (Quarterly): 2.358M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 2.358M |
December 31, 2023 | 3.515M |
September 30, 2023 | 1.827M |
June 30, 2023 | 2.612M |
March 31, 2023 | 3.973M |
December 31, 2022 | 3.587M |
September 30, 2022 | 3.370M |
June 30, 2022 | 2.393M |
March 31, 2022 | 3.474M |
December 31, 2021 | 2.547M |
September 30, 2021 | 2.616M |
June 30, 2021 | 2.110M |
March 31, 2021 | 2.105M |
December 31, 2020 | 2.245M |
September 30, 2020 | 2.168M |
June 30, 2020 | 2.402M |
March 31, 2020 | 2.856M |
December 31, 2019 | 2.863M |
September 30, 2019 | 3.936M |
June 30, 2019 | 3.393M |
March 31, 2019 | 2.586M |
December 31, 2018 | 3.021M |
September 30, 2018 | 3.160M |
June 30, 2018 | 3.703M |
March 31, 2018 | 3.417M |
Date | Value |
---|---|
December 31, 2017 | 3.417M |
September 30, 2017 | 2.806M |
June 30, 2017 | 3.545M |
March 31, 2017 | 4.051M |
December 31, 2016 | 2.879M |
September 30, 2016 | 3.026M |
June 30, 2016 | 2.949M |
March 31, 2016 | 2.765M |
December 31, 2015 | 2.830M |
September 30, 2015 | 2.504M |
June 30, 2015 | 3.203M |
March 31, 2015 | 4.113M |
December 31, 2014 | 3.480M |
September 30, 2014 | 4.436M |
June 30, 2014 | 3.617M |
March 31, 2014 | 2.102M |
December 31, 2013 | 1.452M |
September 30, 2013 | 2.249M |
June 30, 2013 | 1.523M |
March 31, 2013 | 4.181M |
December 31, 2012 | 2.340M |
September 30, 2012 | 5.202M |
June 30, 2012 | 4.306M |
March 31, 2012 | 3.709M |
December 31, 2011 | 4.010M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.827M
Minimum
Sep 2023
3.973M
Maximum
Mar 2023
2.817M
Average
2.614M
Median
Accounts Payable (Quarterly) Benchmarks
Avalo Therapeutics Inc | 0.916M |
iBio Inc | 1.228M |
Ocugen Inc | 1.731M |
Petros Pharmaceuticals Inc | 2.137M |
Moderna Inc | 183.00M |